pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells.
about
Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems.Luminescent/magnetic PLGA-based hybrid nanocomposites: a smart nanocarrier system for targeted codelivery and dual-modality imaging in cancer theranostics.Multifunctional, stimuli-sensitive nanoparticulate systems for drug deliveryPolyetherimide-grafted Fe₃O₄@SiO2₂ nanoparticles as theranostic agents for simultaneous VEGF siRNA delivery and magnetic resonance cell imaging.Biocompatible and biodegradable fibrinogen microspheres for tumor-targeted doxorubicin delivery.Chiral cationic polyamines for chiral microcapsules and siRNA deliveryCombination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation.Enhancing siRNA-based cancer therapy using a new pH-responsive activatable cell-penetrating peptide-modified liposomal system.pH-responsive drug-delivery systems.Drug-conjugated polymers as gene carriers for synergistic therapeutic effect.Nanostructured lipid carriers based temozolomide and gene co-encapsulated nanomedicine for gliomatosis cerebri combination therapy.Targeting and microenvironment-responsive lipid nanocarrier for the enhancement of tumor cell recognition and therapeutic efficiency.Polyaspartamide-doxorubicin conjugate as potential prodrug for anticancer therapy.Nanocaged platforms: modification, drug delivery and nanotoxicity. Opening synthetic cages to release the tiger.Polymers in the Co-delivery of siRNA and Anticancer Drugs for the Treatment of Drug-resistant Cancers.Tumor-targeted delivery of siRNA using fatty acyl-CGKRK peptide conjugates.Dual MMP7-proximity-activated and folate receptor-targeted nanoparticles for siRNA delivery.Synthesis of pH-Cleavable dPG-Amines for Gene Delivery Application.Cleavable PEGylation: a strategy for overcoming the "PEG dilemma" in efficient drug delivery.Co-Delivery of Drugs and Genes Using Polymeric Nanoparticles for Synergistic Cancer Therapeutic Effects.The suppression of metastatic lung cancer by pulmonary administration of polymer nanoparticles for co-delivery of doxorubicin and Survivin siRNA.Dual-responsive dithio-polydopamine coated porous CeO2 nanorods for targeted and synergistic drug delivery.Folate receptor-targeted aminoglycoside-derived polymers for transgene expression in cancer cells.Doxorubicin and anti-VEGF siRNA co-delivery via nano-graphene oxide for enhanced cancer therapy in vitro and in vivo.Sequential release of drugs from hollow manganese ferrite nanocarriers for breast cancer therapyPolymer-based drug delivery systems for cancer treatmentDual passively active tumor-targeting micelles for pH-triggered intracellular anticancer drug release
P2860
Q30361646-685D8C05-480D-4F3F-B787-266D77740A61Q33807175-6BE8A740-69AA-4260-B741-CEA7A06DF1D4Q35809872-C35F456D-BFAF-4366-B714-3E01EE8C0A4FQ35831166-02A9A3EE-4C66-4043-A5E9-8AACE4D6B680Q36037022-1B0A9849-2452-44C8-B3E5-E95C2AE364BAQ37368924-DFA4FC0B-1EF5-493B-97AA-8156FCC47C32Q37469872-C58F9EFB-644F-4389-8B0B-B542B6E6820AQ37735811-907988AB-5D20-43F5-9F12-B4633367F538Q38258883-A95CF8EB-E8A3-47AD-9D92-3B50ED002B99Q38608253-CE611B0D-A7F3-40B2-A658-546636200C25Q38870376-7117DF4D-06DF-458E-96EC-99A2A9F5E462Q38927345-AEF33059-37DD-41C9-B2DC-F305EF353E0BQ38943134-4CF8BB01-E344-4869-908B-2AA58FC0AF1BQ39076542-4B4A937B-214E-46CF-A243-8946253CC2F2Q39125540-34513B1D-367C-4EB4-8758-6FF1D6A98135Q41094538-E6778E9D-FFDE-48F3-99DA-E1A6A3F5FA0CQ43105872-1A66C161-1E2F-4622-9289-83B26880542AQ45856464-08132DD7-16DC-4D3D-94D7-8CD859FC2589Q47288830-86472464-999A-4A27-BC08-6757E676A003Q47642768-50B823E7-6BFC-417A-A7E3-EBE11CFF2CB6Q48971998-63EA7CDE-BBEE-4FA3-A073-883833ABB4D2Q52562723-94B1D2DD-9C09-4FF8-B17A-E98121FD5596Q54942026-7EB05D8D-68CA-46D8-A3E9-5987C38110A4Q55427986-9EC147A9-3952-4EB0-A7AC-C78D07804264Q57173424-7001EBED-8F53-4929-8798-EC9112A36C62Q57353155-25DD5DE7-B305-42D3-AC38-540C123F45F6Q57371949-840E78B6-662F-4D64-B6A4-69CF6960222A
P2860
pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
pH-responsive complexes using ...... cin and siRNA to cancer cells.
@ast
pH-responsive complexes using ...... cin and siRNA to cancer cells.
@en
pH-responsive complexes using ...... cin and siRNA to cancer cells.
@nl
type
label
pH-responsive complexes using ...... cin and siRNA to cancer cells.
@ast
pH-responsive complexes using ...... cin and siRNA to cancer cells.
@en
pH-responsive complexes using ...... cin and siRNA to cancer cells.
@nl
prefLabel
pH-responsive complexes using ...... cin and siRNA to cancer cells.
@ast
pH-responsive complexes using ...... cin and siRNA to cancer cells.
@en
pH-responsive complexes using ...... cin and siRNA to cancer cells.
@nl
P2093
P1433
P1476
pH-responsive complexes using ...... icin and siRNA to cancer cells
@en
P2093
Da-Wen Dong
Jing-Quan Li
Zhen-Zhen Yang
P304
P356
10.1016/J.BIOMATERIALS.2013.03.018
P50
P577
2013-03-27T00:00:00Z